Pfizer turns to ChemAxon for cheminformatics solution
22 January 2010
ChemAxon has entered into agreement with Pfizer to provide its Markush searching and structure enumeration functionality for global development and deployment within Pfizer's global R&D facilities.
'Markush structure search and enumeration is becoming of critical importance for structure IP and patent development,' said Alex Drijver, CEO of ChemAxon. 'It is an area where ChemAxon has developed a high area of expertise and where we are moving very much into the forefront.'
